Literature DB >> 3120608

Interactions between chronic murine Trypanosoma cruzi infection and pregnancy: fetal growth retardation.

Y Carlier1, M T Rivera, C Truyens, F Puissant, J Milaire.   

Abstract

Fetal growth, reproductive capacity, and parasitemia were studied in three groups of BALB/c mice: pregnant and chronically infected with Trypanosoma cruzi, non-pregnant but similarly infected, and pregnant but noninfected. The pregnant mice were killed on day 17 of pregnancy. Comparisons of the two pregnant groups showed significant differences in fetal weights and x18 magnified ossification lengths of radius and cubitus, whereas placental weights were not modified. The results indicate that intrauterine growth retardation occurs during chronic murine T. cruzi infection. No difference was noted between the reproductive capacities of the two pregnant groups. Parasitemias were similar in infected pregnant and control groups. Mice of all groups survived infection until killing. Pregnancy, therefore, does not influence chronic murine T. cruzi infection. Parasites were never found in fetal blood, indicating a very low, if any, frequency of transplacental transmission of parasite during the chronic phase of infection.

Entities:  

Mesh:

Year:  1987        PMID: 3120608     DOI: 10.4269/ajtmh.1987.37.534

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  8 in total

1.  Acute Trypanosoma cruzi infection in mouse induces infertility or placental parasite invasion and ischemic necrosis associated with massive fetal loss.

Authors:  Abdelkarim Mjihdi; Marie-Alexandra Lambot; Ian J Stewart; Olivier Detournay; Jean-Christophe Noël; Yves Carlier; Carine Truyens
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

2.  Seroprevalence of Trypanosoma cruzi among mothers and children in rural Mayan communities and associated reproductive outcomes.

Authors:  Rubi Gamboa-León; Claudia Ramirez-Gonzalez; Freddy S Pacheco-Tucuch; Matthew O'Shea; Kathryn Rosecrans; Julia Pippitt; Eric Dumonteil; Pierre Buekens
Journal:  Am J Trop Med Hyg       Date:  2014-06-16       Impact factor: 2.345

3.  Interleukin-6 (IL-6) production in mice infected with Trypanosoma cruzi: effect of its paradoxical increase by anti-IL-6 monoclonal antibody treatment on infection and acute-phase and humoral immune responses.

Authors:  C Truyens; A Angelo-Barrios; F Torrico; J Van Damme; H Heremans; Y Carlier
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

4.  An Fc gamma RII-, Fc gamma RIII-specific monoclonal antibody (2.4G2) decreases acute Trypanosoma cruzi infection in mice.

Authors:  T Araujo-Jorge; M T Rivera; A el Bouhdidi; M Daëron; Y Carlier
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

5.  High tumor necrosis factor alpha (TNF-alpha) production in Trypanosoma cruzi-infected pregnant mice and increased TNF-alpha gene transcription in their offspring.

Authors:  M T Rivera; S Marques de Araujo; R Lucas; J Deman; C Truyens; M P Defresne; P de Baetselier; Y Carlier
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

6.  Parasitic loads in tissues of mice infected with Trypanosoma cruzi and treated with AmBisome.

Authors:  Sabrina Cencig; Nicolas Coltel; Carine Truyens; Yves Carlier
Journal:  PLoS Negl Trop Dis       Date:  2011-06-28

7.  Different genotypes of Trypanosoma cruzi produce distinctive placental environment genetic response in chronic experimental infection.

Authors:  Natalia Anahí Juiz; María Elisa Solana; Gonzalo Raúl Acevedo; Alejandro Francisco Benatar; Juan Carlos Ramirez; Priscilla Almeida da Costa; Andrea Mara Macedo; Silvia Andrea Longhi; Alejandro G Schijman
Journal:  PLoS Negl Trop Dis       Date:  2017-03-08

8.  Fertility, gestation outcome and parasite congenital transmissibility in mice infected with TcI, TcII and TcVI genotypes of Trypanosoma cruzi.

Authors:  Sabrina Cencig; Nicolas Coltel; Carine Truyens; Yves Carlier
Journal:  PLoS Negl Trop Dis       Date:  2013-06-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.